公司为国内最大的滴丸剂型生产商。主要生产以预防、治疗心脑血管疾病为主的系列药品,2004年底总资产22.01亿元,销售收入13.02亿元,利润额2.15亿元,对应在全国的占比分别为1.78%、1.84%、2.89%,从利润额占比情况可以看出公司的经营效率明显高于行业平均水平。目前公司在中国的 The company is the largest manufacturer of drip pills in the country. Mainly to prevent and treat cardiovascular disease-based series of drugs, the end of 2004 the total assets of 2.201 billion yuan, sales revenue 1.302 billion yuan, profit 215 million yuan, corresponding to the national share of 1.78%, 1.84%, respectively, 2.89%. According to the proportion of profit, we can see that the operating efficiency of the company is obviously higher than the industry average. Currently the company is in China